Tensions between Japan and South Korea come as the U.S. and its trading partners are embroiled in a global trade war.Technologyread more
The one-to-eight stock split would mean the current number of ordinary shares — which stands at 4 billion — will increase to 32 billion. It comes ahead of a reported Hong Kong...Asia Marketsread more
Minutes from the Reserve Bank of Australia's monetary policy meeting in July showed the central bank was ready to adjust interest rates if required.Asia Marketsread more
Current and former Tesla employees working in the company's open-air "tent" factory say they felt pressure to take shortcuts to hit aggressive Model 3 production goals,...Technologyread more
China's fiscal spending increased 10.7% in the first six months from a year earlier, the finance ministry said on Tuesday, underlining the government's bid to support the...China Economyread more
The findings by McKinsey and Company come amid a year-long tariff fight between the U.S. and China, which has spilled into areas such as technology and security.China Economyread more
Microsoft's considerable reach into the corporate world isn't something Slack CEO Stewart Butterfield is very concerned about.Technologyread more
A devastating outbreak of African swine fever that has killed millions of pigs in China is changing attitudes in a country where farm hygiene has often been seen as lax by...Livestockread more
In a closed-door meeting at a Manhattan mansion, executives outlined changes to controversial software that was implicated in two crashes.Aerospace & Defenseread more
President Donald Trump and the RNC are picking up key supporters in the business community who did not back him as a candidate in 2016.2020 Electionsread more
Amazon workers in Minnesota and Germany are striking as Prime Day kicks off, in a stand against working conditions and wage practices. The action in Minnesota represents the...Retailread more
Humana executives say they are modeling a number of scenarios to try to figure out how they'll price their Medicare drug plans for 2020 as the health insurance industry awaits new pharmacy benefit rebate regulations expected this spring from the Trump administration.
"We're spending a lot of time at Humana doing some game theory, a variety of different ways to try to understand what different options we have here, depending on the rule -- the specifications of the rules," Alan Wheatley, president of Humana's Medicare, Medicaid and specialty health plans division, said earlier this week at the company's investor day.
Wheatley told investors Tuesday that the Trump proposal to force Medicare plans to pass on negotiated drug discounts to consumers at the pharmacy counter would result in lower prices for its members using brand names drugs, but there will be trade-offs.
Standard prescription drug plans will likely adjust the scope of the drugs they cover, known as the formulary, or increase premiums, or some combination of the two, executives said.
The game theory comes in with the timing of when new rules might be adopted. Executives note the deadline for filing 2020 plans is in early June.
"To the extent that the rebate proposal doesn't go through, we also have to be mindful about how manufacturers are going to behave as we bid for 2020 and so we're very focused on that," said Brian Kane, Humana CFO.
The company's central focus this year is on developing its technology and data analytics, with some executives directly comparing the company's efforts to that of Amazon, in trying to build a platform where others can plug in to offer digital health services that will help coordinate care for members.
"We see customer preferences changing and being more demanding … 'make it simple for me, make it easier … know me, personalize the interaction," said CEO Bruce Broussard.
The company is building out a new digital health hub in Boston, dubbed Studio H. Despite a competitive environment for talent, executives claim they are having no trouble filling technology positions.
"We're finding we have more demand than we have open jobs right now which is a great problem, we don't even have to advertise," said Heather Cox, chief digital health and analytics officer.
The company maintained its earnings outlook of $17 to $17.50 per share for 2019. Humana shares are down 4.5 percent so far this year.